Primož Rožman

2.2k total citations
66 papers, 1.7k citations indexed

About

Primož Rožman is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Primož Rožman has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 15 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Primož Rožman's work include Hematopoietic Stem Cell Transplantation (12 papers), Blood groups and transfusion (11 papers) and Platelet Disorders and Treatments (9 papers). Primož Rožman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Blood groups and transfusion (11 papers) and Platelet Disorders and Treatments (9 papers). Primož Rožman collaborates with scholars based in Slovenia, United States and Austria. Primož Rožman's co-authors include Urban Švajger, Helena Meden‐Vrtovec, Branko Cvjetičanin, Irma Virant‐Klun, Elvira Maličev, Christoph Gassner, Nicolas H. Zech, Andrej Vogler, Dragica Smrke and Srdjan Novaković and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Primož Rožman

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Primož Rožman Slovenia 22 478 473 305 263 229 66 1.7k
Price Blair United States 13 258 0.5× 699 1.5× 214 0.7× 74 0.3× 221 1.0× 16 1.7k
Osamu Ishiko Japan 25 537 1.1× 160 0.3× 384 1.3× 233 0.9× 106 0.5× 174 2.4k
Neal Paragas United States 14 871 1.8× 209 0.4× 243 0.8× 114 0.4× 109 0.5× 19 2.0k
Soledad Negrotto Argentina 26 766 1.6× 538 1.1× 166 0.5× 100 0.4× 93 0.4× 48 2.0k
Nancy S. Rosenthal United States 19 417 0.9× 354 0.7× 353 1.2× 94 0.4× 42 0.2× 50 1.9k
José E. Cardier Venezuela 20 331 0.7× 378 0.8× 117 0.4× 236 0.9× 55 0.2× 55 1.3k
Mireille Redard Switzerland 17 733 1.5× 114 0.2× 519 1.7× 389 1.5× 83 0.4× 28 2.6k
Alex Zvulunov Israel 23 289 0.6× 82 0.2× 390 1.3× 87 0.3× 96 0.4× 59 1.5k
Pierre‐André Guerne Switzerland 25 407 0.9× 191 0.4× 251 0.8× 38 0.1× 76 0.3× 40 1.9k
J.‐H. Saurat Switzerland 25 332 0.7× 204 0.4× 127 0.4× 83 0.3× 51 0.2× 77 2.3k

Countries citing papers authored by Primož Rožman

Since Specialization
Citations

This map shows the geographic impact of Primož Rožman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Primož Rožman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Primož Rožman more than expected).

Fields of papers citing papers by Primož Rožman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Primož Rožman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Primož Rožman. The network helps show where Primož Rožman may publish in the future.

Co-authorship network of co-authors of Primož Rožman

This figure shows the co-authorship network connecting the top 25 collaborators of Primož Rožman. A scholar is included among the top collaborators of Primož Rožman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Primož Rožman. Primož Rožman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maličev, Elvira, et al.. (2023). Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19. Transfusion Medicine and Hemotherapy. 51(3). 175–184.
2.
Žiberna, Klemen, et al.. (2022). ABO blood group does not influence the level of anti‐SARS‐CoV ‐2 antibodies in convalescent plasma donors. Transfusion. 62(3). 556–562. 7 indexed citations
3.
Švajger, Urban, Uroš Rajčević, Tanja Švara, et al.. (2022). The Influence of Heterochronic Non-Myeloablative Bone Marrow Transplantation on the Immune System, Frailty, General Health, and Longevity of Aged Murine Recipients. Biomolecules. 12(4). 595–595. 4 indexed citations
4.
Švajger, Urban, et al.. (2021). Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ. International Immunopharmacology. 99. 107978–107978. 10 indexed citations
5.
Švajger, Urban & Primož Rožman. (2021). Mixed cultures of allogeneic dendritic cells are phenotypically and functionally stable – a potential for primary cell-based “off the shelf” product generation. Central European Journal of Immunology. 46(2). 152–161. 1 indexed citations
6.
Henzel, Kristin S., et al.. (2020). Effects of heterochronic, non-myeloablative bone marrow transplantation on age-related behavioural changes in mice. Mechanisms of Ageing and Development. 191. 111327–111327. 2 indexed citations
7.
Rožman, Primož, et al.. (2019). MOLECULAR MECHANISMS OF STEM CELL AGING. SHILAP Revista de lepidopterología. 56(1). 2 indexed citations
9.
Švajger, Urban, et al.. (2018). Chimerism and gene therapy — Lessons learned from non‐conditioned murine bone marrow transplantation models. European Journal Of Haematology. 100(4). 372–382. 5 indexed citations
11.
Rožman, Primož & Urban Švajger. (2018). The tolerogenic role of IFN-γ. Cytokine & Growth Factor Reviews. 41. 40–53. 63 indexed citations
13.
Perme, Maja Pohar, et al.. (2017). The effect of CD34 + cell telomere length and hTERT expression on the outcome of autologous CD34 + cell transplantation in patients with chronic heart failure. Mechanisms of Ageing and Development. 166. 42–47. 4 indexed citations
14.
Blejec, Andrej, Urška Verbovšek, Marjan Koršič, et al.. (2014). Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach. Radiology and Oncology. 48(3). 257–266. 12 indexed citations
15.
Smrke, Dragica, et al.. (2014). An uncommon treatment of totally extruded and lost talus: a case report. Journal of Medical Case Reports. 8(1). 322–322. 10 indexed citations
16.
Baş, Tuba Öcek, et al.. (2012). The hazards of DAPI photoconversion: effects of dye, mounting media and fixative, and how to minimize the problem. Histochemistry and Cell Biology. 139(1). 195–204. 24 indexed citations
17.
Rožman, Primož, et al.. (2010). Naturally occurring anti-E red-cell antibodies in a 3-month old infant. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Virant‐Klun, Irma, Primož Rožman, Branko Cvjetičanin, et al.. (2008). Parthenogenetic Embryo-Like Structures in the Human Ovarian Surface Epithelium Cell Culture in Postmenopausal Women with No Naturally Present Follicles and Oocytes. Stem Cells and Development. 18(1). 137–150. 115 indexed citations
20.
Rožman, Primož, et al.. (1992). Tissue sulfate determination by ion chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 574(1). 146–149. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026